Filing Analysis
Officer Departure
Filed May 01, 2026
LOW
AVITA Medical has appointed Cary Vance as its permanent President and CEO, effective April 30, 2026, following his service as Interim CEO since October 2025. The company also restructured its board leadership, appointing Jan Stern Reed as Chair of the Board.
Key Facts
- Cary Vance appointed permanent President and CEO effective April 30, 2026.
- Vance's compensation includes a base salary of $702,000 and an 80% target bonus.
- Equity grants totaling approximately $3.35 million ($2,529,000 in RSUs/options and $825,000 in RSUs) are subject to stockholder approval at the 2027 Annual Meeting.
- Jan Stern Reed appointed Chair of the Board, terminating the Lead Independent Director position.
- Vance has 30 years of healthcare leadership experience, including executive roles at GE HealthCare and Covidien.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.